Galactosyl Prodrug of Palmitoylethanolamide: Synthesis, Stability, Cell Permeation and Cytoprotective Activity
Articolo
Data di Pubblicazione:
2014
Citazione:
Galactosyl Prodrug of Palmitoylethanolamide: Synthesis, Stability, Cell Permeation and Cytoprotective Activity / Luongo, E., Russo, R., Avagliano, C., A., S.A., Melisi, D., Orefice, N.S., Mattace Raso, G., Meli, R., Magliocca, S., Nieddu, M., Pinheiro Santiago, G.M., Boatto, G., Calignano, A., Rimoli, M.G.. - In: EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES. - ISSN 0928-0987. - 62:(2014), pp. 33-39. [10.1016/j.ejps.2014.05.009]
Abstract:
N-Palmitoylethanolamide (PEA) is emerging as a novel therapeutic agent in the treatment of neuropathic pain and neurodegenerative diseases. Unfortunately, PEA poorly reaches the central nervous system (CNS), after peripheral administration, since it is inactivated through intracellular hydrolysis by lipid amidases. Since prodrug approach is one of the most popular methods used to increase cell permeability, the aim of this paper consists in the synthesis of a new galactosyl prodrug of PEA, the palmitoylethanolamide-
succinamyl-D-galactos-60-yl ester (PEAGAL). Biological experiments both in neuroblastoma and in C6 glioma cells, together with quantitative analyses performed through a LC–MS–MS technique, demonstrate the better efficacy of PEAGAL compared to PEA and its higher cell permeation. Our results encourage further experiments in animal models of neuropathic pain and of neurological disorders and/or
neurodegenerative diseases, in order to promote a more effective peripherally administrated derivative of PEA.
succinamyl-D-galactos-60-yl ester (PEAGAL). Biological experiments both in neuroblastoma and in C6 glioma cells, together with quantitative analyses performed through a LC–MS–MS technique, demonstrate the better efficacy of PEAGAL compared to PEA and its higher cell permeation. Our results encourage further experiments in animal models of neuropathic pain and of neurological disorders and/or
neurodegenerative diseases, in order to promote a more effective peripherally administrated derivative of PEA.
Tipologia CRIS:
1.1 Articolo in rivista
Keywords:
N-Palmitoylethanolamide; Prodrugs; Cell culture; Permeability; Cytoprotection; Liquid chromatography
Elenco autori:
Luongo, E; Russo, R; Avagliano, C; A., Santoro A; Melisi, D; Orefice, N. S.; Mattace Raso, G; Meli, R; Magliocca, S; Nieddu, M; Pinheiro Santiago, G. M.; Boatto, Gianpiero; Calignano, A; Rimoli, M. G.
Link alla scheda completa:
Pubblicato in: